A Study Evaluating a Proprietary Amino Acid Mixture (EnteradeÂ®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma